Jackson D B, Thompson C, McCormack J R, Guin J D
Department of Dermatology, College of Medicine, University of Arkansas for Medical Sciences.
J Am Acad Dermatol. 1989 May;20(5 Pt 1):791-6. doi: 10.1016/s0190-9622(89)70091-8.
A new, quantitative modification of the vasoconstrictor assay was used to measure bioavailability of generic topical corticosteroid products in two categories: betamethasone valerate 0.1% cream and triamcinolone 0.1% cream. Betamethasone valerate products could be separated into two distinct categories, and triamcinolone acetonide products could be grouped into three categories of activity. A survey of local pharmacies showed that generic substitution would be made for the prescribed brand of betamethasone valerate in 58% of cases and for the prescribed triamcinolone acetonide 75% of the time. Because of the prevalence of generic substitution of products that may not have equivalent bioavailability, some standardization of the bioavailability of topical products is needed.